Hao Jinxia
Department of Cardiothoracic, Cangzhou Central Hospital Hebei Province, China.
Am J Transl Res. 2022 Jul 15;14(7):5132-5138. eCollection 2022.
To explore the application value of enhanced recovery after surgery (ERAS) for heart valve replacement surgery.
A total of 86 patients with heart valve diseases admitted to our hospital from Jan. 2018 to Mar. 2020 were selected, and randomized into the control group (n=43) with regular nursing care and the observation group (n=43) with ERAS. The postoperative recovery, rate of adverse events, quality of life, visual analogue scale (VAS) score and nursing care satisfaction rate were compared between the two groups.
After surgery, the time to first bowel movement and the first flatulence in the observation group were earlier than those in the control group, and the hospital stay of patients in the observation group was shorter than that in the control group. The rate of adverse events in the observation group was 4.65%, which was lower than that in the control group (18.60%). In addition, the observation group obtained higher life quality scores but lower VAS, self-rating anxiety scale (SAS) and self-rating depression scale (SDS) scores than the control group, and the observation group showed lower serum levels of corticotropin and cortisol and exhibited a longer 6-minute walking distance than the control group. Moreover, the nursing care satisfaction rate of the observation group was 95.35%, which was higher than that (76.74%) of the control group (all P<0.05).
ERAS can reduce adverse events and pain for patients with heart valve replacement and improve their postoperative recovery, quality of life, and nursing care satisfaction.
探讨加速康复外科（ERAS）在心脏瓣膜置换手术中的应用价值。
选取2018年1月至2020年3月我院收治的86例心脏瓣膜病患者，随机分为对照组（n = 43），给予常规护理；观察组（n = 43），给予ERAS。比较两组患者术后恢复情况、不良事件发生率、生活质量、视觉模拟评分法（VAS）评分及护理满意度。
术后，观察组首次排便和首次排气时间早于对照组，观察组患者住院时间短于对照组。观察组不良事件发生率为4.65%，低于对照组（18.60%）。此外，观察组生活质量评分高于对照组，VAS、自评焦虑量表（SAS）和自评抑郁量表（SDS）评分低于对照组，观察组血清促肾上腺皮质激素和皮质醇水平较低，6分钟步行距离长于对照组。而且，观察组护理满意度为95.35%，高于对照组（76.74%）（均P < 0.05）。
ERAS可减少心脏瓣膜置换患者的不良事件和疼痛，提高其术后恢复情况、生活质量及护理满意度。
